Wave Life Sciences Ltd (NASDAQ: WVE) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
Wave Life Sciences Ltd. - Ordinary Shares (WVE)
Last wave life sciences ltd. - ordinary shares earnings: 3/2 06:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.wavelifesciences.com/news-releases?page=1%2c0%2c0%2c0
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
WVE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
WVE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
WVE alerts
High impacting Wave Life Sciences Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
WVE
News
- Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at Royal Bank of Canada from $5.00 to $7.00. They now have a "sector perform" rating on the stock.MarketBeat
- Wave Life Sciences Ltd. (NASDAQ: WVE) had its price target raised by analysts at B. Riley from $11.00 to $19.00. They now have a "buy" rating on the stock.MarketBeat
- Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares GlobeNewswire
- Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines ConferenceGlobeNewswire
- Wave Life Sciences Ltd. (NASDAQ: WVE) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $13.00 price target on the stock.MarketBeat
WVE
Earnings
- 8/8/24 - Miss
WVE
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form SC
- 10/1/24 - Form 8-K
- WVE's page on the SEC website